Rayner, Brian

Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study

Dehghan, M., Mente, A., Zhang, X., Swaminathan, S., Li, W., Mohan, V., Iqbal, R., Kumar, R., Wentzel-Viljoen, E., Rosengren, A., et al. (2017) · The Lancet

Nutritional Studies and DietFatty Acid Research and Health

Cited by 1,101

Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial

Tuttle, K. R., Lakshmanan, M. C., Rayner, B., Busch, R. S., Zimmermann, A. G., Woodward, D. B., & Botros, F. T. (2018) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 648

Mobile Phone Text Messages to Support Treatment Adherence in Adults With High Blood Pressure (SMS-Text Adherence Support [StAR]): A Single-Blind, Randomized Trial

Bobrow, K., Farmer, A. J., Springer, D., Shanyinde, M., Yu, L.-M., Brennan, T., Rayner, B., Namane, M., Steyn, K., Tarassenko, L., et al. (2016) · Circulation

Mobile Health and mHealth ApplicationsMedication Adherence and Compliance

Cited by 295

Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study

Mente, A., Dehghan, M., Rangarajan, S., McQueen, M., Dagenais, G., Wielgosz, A., Lear, S., Li, W., Chen, H., Yi, S., et al. (2017) · The Lancet Diabetes & Endocrinology

Nutritional Studies and DietFatty Acid Research and Health

Cited by 268

Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Attaei, M. W., Khatib, R., McKee, M., Lear, S., Dagenais, G., Igumbor, E. U., AlHabib, K. F., Kaur, M., Kruger, L., Teo, K., et al. (2017) · The Lancet Public Health

Blood Pressure and Hypertension StudiesPharmaceutical Economics and Policy

Cited by 209

Roadmap to Achieve 25% Hypertension Control in Africa by 2025

Dzudie, A., Rayner, B., Ojji, D., Schutte, A. E., Twagirumukiza, M., Damasceno, A., Ba, S. A., Kane, A., Kramoh, E., Anzouan Kacou, J. B., et al. (2018) · Global Heart

Blood Pressure and Hypertension StudiesClinical practice guidelines implementation

Cited by 119

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis

Agarwal, R., Tu, W., Farjat, A. E., Farag, Y. M. K., Toto, R., Kaul, S., Lawatscheck, R., Rohwedder, K., Ruilope, L. M., Rossing, P., et al. (2023) · Annals of Internal Medicine

Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension

Cited by 109

Efficacy of a text messaging (SMS) based intervention for adults with hypertension: protocol for the StAR (SMS Text-message Adherence suppoRt trial) randomised controlled trial

Bobrow, K., Brennan, T., Springer, D., Levitt, N. S., Rayner, B., Namane, M., Yu, L.-M., Tarassenko, L., & Farmer, A. (2014) · BMC Public Health

Mobile Health and mHealth ApplicationsMedication Adherence and Compliance

Cited by 83

Clinical outcomes by albuminuria status with dulaglutide versus insulin glargine in participants with diabetes and CKD: AWARD-7 exploratory analysis

Tuttle, K. R., Rayner, B., Lakshmanan, M. C., Kwan, A. Y. M., Konig, M., Shurzinske, L., & Botros, F. T. (2021) · Kidney360

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 42